Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) Will Post Quarterly Sales of $6.88 Million

Brokerages predict that Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) will announce sales of $6.88 million for the current quarter, Zacks reports. Two analysts have issued estimates for Molecular Templates’ earnings, with the highest sales estimate coming in at $8.75 million and the lowest estimate coming in at $5.00 million. Molecular Templates posted sales of […]

Related Keywords

,Geode Capital Management ,Zacks Investment Research ,Blackrock Inc ,Bellevue Group ,Barclays ,Molecular Templates Inc ,Nasdaq ,Molecular Templates ,Get Rating ,Molecular Template ,Investment Research ,Capital Partners ,Capital Management ,Nasdaq Mtem ,Temtem ,Medical ,88580720 ,Ratings ,Consensus ,